Cargando…
RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential
Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological func...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058657/ http://dx.doi.org/10.3390/ph4091248 |
_version_ | 1782321152183500800 |
---|---|
author | Findeisen, Maria Rathmann, Daniel Beck-Sickinger, Annette G. |
author_facet | Findeisen, Maria Rathmann, Daniel Beck-Sickinger, Annette G. |
author_sort | Findeisen, Maria |
collection | PubMed |
description | Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological functions, like important neuroendocrine, behavioral, sensory and automatic functions. The RFamide peptide receptor family represents a multiligand/multireceptor system, as many ligands are recognized by several GPCR subtypes within one family. Multireceptor systems are often susceptible to cross-reactions, as their numerous ligands are frequently closely related. In this review we focus on recent results in the field of structure-activity studies as well as mutational exploration of crucial positions within this GPCR system. The review summarizes the reported peptide analogs and recently developed small molecule ligands (agonists and antagonists) to highlight the current understanding of the pharmacophoric elements, required for affinity and activity at the receptor family. Furthermore, we address the biological functions of the ligands and give an overview on their involvement in physiological processes. We provide insights in the knowledge for the design of highly selective ligands for single receptor subtypes to minimize cross-talk and to eliminate effects from interactions within the GPCR system. This will support the drug development of members of the RFamide family. |
format | Online Article Text |
id | pubmed-4058657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-40586572014-06-16 RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential Findeisen, Maria Rathmann, Daniel Beck-Sickinger, Annette G. Pharmaceuticals (Basel) Review Different neuropeptides, all containing a common carboxy-terminal RFamide sequence, have been characterized as ligands of the RFamide peptide receptor family. Currently, five subgroups have been characterized with respect to their N-terminal sequence and hence cover a wide pattern of biological functions, like important neuroendocrine, behavioral, sensory and automatic functions. The RFamide peptide receptor family represents a multiligand/multireceptor system, as many ligands are recognized by several GPCR subtypes within one family. Multireceptor systems are often susceptible to cross-reactions, as their numerous ligands are frequently closely related. In this review we focus on recent results in the field of structure-activity studies as well as mutational exploration of crucial positions within this GPCR system. The review summarizes the reported peptide analogs and recently developed small molecule ligands (agonists and antagonists) to highlight the current understanding of the pharmacophoric elements, required for affinity and activity at the receptor family. Furthermore, we address the biological functions of the ligands and give an overview on their involvement in physiological processes. We provide insights in the knowledge for the design of highly selective ligands for single receptor subtypes to minimize cross-talk and to eliminate effects from interactions within the GPCR system. This will support the drug development of members of the RFamide family. MDPI 2011-09-21 /pmc/articles/PMC4058657/ http://dx.doi.org/10.3390/ph4091248 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Findeisen, Maria Rathmann, Daniel Beck-Sickinger, Annette G. RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential |
title | RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential |
title_full | RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential |
title_fullStr | RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential |
title_full_unstemmed | RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential |
title_short | RFamide Peptides: Structure, Function, Mechanisms and Pharmaceutical Potential |
title_sort | rfamide peptides: structure, function, mechanisms and pharmaceutical potential |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058657/ http://dx.doi.org/10.3390/ph4091248 |
work_keys_str_mv | AT findeisenmaria rfamidepeptidesstructurefunctionmechanismsandpharmaceuticalpotential AT rathmanndaniel rfamidepeptidesstructurefunctionmechanismsandpharmaceuticalpotential AT becksickingerannetteg rfamidepeptidesstructurefunctionmechanismsandpharmaceuticalpotential |